Home    中文  
 
  • Search
  • lucene Search
  • Citation
  • Fig/Tab
  • Adv Search
Just Accepted  |  Current Issue  |  Archive  |  Featured Articles  |  Most Read  |  Most Download  |  Most Cited

Chinese Journal of Cell and Stem Cell(Electronic Edition) ›› 2018, Vol. 08 ›› Issue (01): 35-38. doi: 10.3877/cma.j.issn.2095-1221.2018.01.007

Special Issue:

• Review • Previous Articles     Next Articles

Research progress of tumor - associated mesenchymal stem cells and its targeted therapy

Ping Wang1, Yujie Ma1, jun Lu1, Qinghua Wang1, Jianming Tan1,()   

  1. 1. Organ Transplant Institute, Fuzhou General Hospital, Fujian Key Laboratory of Transplant Biology, Fuzhou 350025, China
  • Received:2017-07-10 Online:2018-02-01 Published:2018-02-01
  • Contact: Jianming Tan
  • About author:
    Corresponding author:Tan Jianming, Email:

Abstract:

Mesenchymal stem cells exist in many tissues and are known to actively migrate to sites of tissue injury, where they participate in wound repair. Tumours can be considered "wounds that never heal" and, in response to cues from a tumour, MSCs are continuously recruited to and become integral components of the tumour microenvironment. Recently, it has become apparent that such tumour-associated MSCs (TA-MSCs) have an active role in tumour initiation, promotion, progression and metastasis. In this review, we discuss recent advances of association of the MSC and AT-MSC and address in our understanding of the role of TA-MSCs in regulating the survival, proliferation, migration and drug resistance of tumour cells. Moreover, we discuss therapeutic approaches that target TA-MSC upstream or downstream modulators or use MSCs as vehicles for the delivery of tumoricidal agents.

Key words: Mesenchymal stem cells, Tumour-associated, Targeted therapy

京ICP 备07035254号-3
Copyright © Chinese Journal of Cell and Stem Cell(Electronic Edition), All Rights Reserved.
Tel: 0086-591-87982783 E-mail: ccsct@vip.163.com
Powered by Beijing Magtech Co. Ltd